Lactoferrin coated or conjugated nanomaterials as an active targeting approach in nanomedicine.

International Journal of Biological Macromolecules
Mona M Agwa, Sally Sabra

Abstract

A successful drug delivery to a specific site relies on two essential factors including; efficient entrapment of the drug within the carrier and successful delivery of drug- loaded nanocarrier to the target site without opsonisation or drug release in the circulation before reaching the organ of interest. Lactoferrin (LF) is a glycoprotein belonging to the transferrin (TF) family which can bind to TF receptors (TFRs) and LF membrane internalization receptors (LFRs) highly expressed on the cell surface of both highly proliferating cancer cells and blood brain barrier (BBB), which in turn can facilitate its accessibility to the cell nucleus. This merit could be exploited to develop actively targeted drug delivery systems that can easily cross the BBB or internalize into tumor cells. In this review, the most recent advances of utilizing LF as an active targeting ligand for different types of nanocarriers including: inorganic nanoparticles, dendrimers, synthetic biodegradable polymers, lipid nanocarriers, natural polymers, and nanoemulstions will be highlighted. Collectively, LF seems to be a promising targeting ligand in the field of nanomedicine.

References

Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·B A FaucheuxY Agid
Apr 1, 1994·Analytical Biochemistry·D Sehgal, I K Vijay
Dec 11, 1999·Biochimica Et Biophysica Acta·R M Epand, H J Vogel
Jun 6, 2000·Advanced Drug Delivery Reviews·E MastrobattistaG Storm
Sep 1, 2000·Advanced Drug Delivery Reviews·S P Vyas, V Sihorkar
Jun 23, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Telse Richter, Sigrid Keipert
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·William M Pardridge
Sep 17, 2005·Life Sciences·Bin JiTetsuya Suhara
Nov 29, 2005·Advanced Drug Delivery Reviews·Christine DufèsAndreas G Schätzlein
Jan 2, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Kevin Letchford, Helen Burt
Jan 16, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rong-Qin HuangChen Jiang
Jul 20, 2007·The Journal of Pharmacy and Pharmacology·Yashwant GuptaSanjay K Jain
Sep 14, 2007·International Journal of Pharmaceutics·Haizheng Zhao, Lin Yue Lanry Yung
Apr 5, 2008·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Celia ConesaRobert W Evans
Sep 23, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Karsten UlbrichJörg Kreuter
Nov 29, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kaili HuXinguo Jiang
Aug 6, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Rongqin HuangYuanying Pei
Nov 17, 2009·Journal of the Neurological Sciences·Rongqin HuangYuanying Pei
Dec 1, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Swati KoppuChristine Dufès
Dec 23, 2009·Brain Research Bulletin·Rongqin HuangYuanying Pei
Mar 20, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Huali ChenQin He
Feb 18, 2011·Journal of Biomedical Nanotechnology·Satheesh Podaralla, Omathanu Perumal
Apr 15, 2011·Journal of Pharmaceutical Sciences·Balak D KurmiNarendra K Jain
Jul 5, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Huang-Chiao HuangKaushal Rege
Jul 26, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Huali ChenQin He
Mar 1, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Minyan WeiChuanbin Wu
Jul 18, 2012·Drug Development and Industrial Pharmacy·Jigar LalaniAmbikanandan Misra
Aug 30, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·William M Pardridge
Oct 4, 2012·Journal of Biomedical Nanotechnology·Jigar LalaniAmbikanandan Misra
Jul 1, 2012·Drug Discovery Today. Technologies
Oct 16, 2013·International Journal of Pharmaceutics·Yajing YeWei Wang

❮ Previous
Next ❯

Citations

May 1, 2021·International Journal of Molecular Sciences·Zuzanna Flis, Edyta Molik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.